Picture of Takeda Pharmaceutical logo

4502 — Takeda Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareConservativeLarge CapMomentum Trap

Brief: Takeda Pharmaceutical Conducted Thorough Assessment, Found There Was No Confirmed Causal Relationship To Use Of Adzynma &Patient Death - Spokesperson

Nov 21 (Reuters) - Takeda Pharmaceutical Co Ltd 4502.T:

TAKEDA PHARMACEUTICAL: CONDUCTED THOROUGH ASSESSMENT, FOUND THERE WAS NO CONFIRMED CAUSAL RELATIONSHIP TO USE OF ADZYNMA &PATIENT DEATH - SPOKESPERSON

Further company coverage: 4502.T

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Takeda Pharmaceutical

See all news